Radiopharm Theranostics (RADX) Institutional Ownership $5.67 +0.02 (+0.35%) As of 02:21 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Radiopharm Theranostics (NASDAQ:RADX)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$37.12KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$134.40K Get RADX Insider Trade Alerts Want to know when executives and insiders are buying or selling Radiopharm Theranostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Radiopharm Theranostics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Affinity Asset Advisors LLC35,635$166K0.0%-44.8%0.452% 8/8/2025 PNC Financial Services Group Inc.8,000$37K0.0%N/A0.102% 5/14/2025 Affinity Asset Advisors LLC64,600$311K0.0%-58.6%0.861% (Data available from 1/1/2016 forward) RADX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RADX shares? During the previous two years, the following institutional investors and hedge funds held shares of Radiopharm Theranostics shares: Affinity Asset Advisors LLC ($166K), PNC Financial Services Group Inc. ($37K).Learn more on Radiopharm Theranostics' institutional investors. Which institutional investors have been buying Radiopharm Theranostics' stock? The following institutional investors have purchased Radiopharm Theranostics' stock in the last 24 months: PNC Financial Services Group Inc. ($8K). How much institutional buying is happening at Radiopharm Theranostics? Institutional investors have bought a total of 8,000 shares in the last 24 months. This purchase volume represents approximately $37.12K in transactions. Which of Radiopharm Theranostics' major shareholders have been selling company stock? The following institutional investors have sold Radiopharm Theranostics stock in the last 24 months: Affinity Asset Advisors LLC ($120.54K). How much institutional selling is happening at Radiopharm Theranostics? Institutional investors have sold a total of 120,536 shares in the last 24 months. This volume of shares sold represents approximately $134.40K in transactions. Related Companies NKTX Institutional Ownership ELDN Institutional Ownership SLS Institutional Ownership TNYA Institutional Ownership KYTX Institutional Ownership BHST Institutional Ownership MXCT Institutional Ownership THTX Institutional Ownership MCRB Institutional Ownership AGEN Institutional Ownership This page (NASDAQ:RADX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Radiopharm Theranostics Limited - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Radiopharm Theranostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access